Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Bora Pharmaceuticals and Celltrion Partners to Expand OSD Capabilities in APAC Market

Friday, March 31, 2023

Bora Pharmaceuticals Co Ltd and Celltrion Asia Pacific Pte Ltd a subsidiary of Celltrion Group Inc have today announced their partnership to contract manufacture and commercialize a range of oral dosage form drugs OSD across the APAC region The range...

Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus

Friday, March 31, 2023

Cabaletta Bio Inc a clinicalstage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases today announced that the Companys Investigational New Drug IND application fo...

Renovion Receives FDA Fast Track Designation for ARINA-1 for the Prevention of BOS Progression in LT

Thursday, March 30, 2023

Renovion Inc announced today that the US Food and Drug Administration FDA has granted Fast Track designation to ARINA for the prevention of bronchiolitis obliterans syndrome BOS progression in adults with a bilateral lung transplant The FDA grants Fa...

Gandeeva and Moderna Enter into Cryo-EM Research Collaboration to Explore Protein Surface Structure at Atomic Resolution

Thursday, March 30, 2023

Gandeeva Therapeutics Inc a precision medicine company focused on designing and developing novel therapeutics guided by cryogenic electron microscopy cryoEM and machine learning announced today the initiation of a research collaboration with Moderna...

Decibel Therapeutics Receives European Orphan Drug Designation for Lead Gene Therapy Candidate DB-OTO

Thursday, March 30, 2023

Decibel Therapeutics a clinicalstage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance today announced that the European Medicines Agency EMA Committee on Orphan Medicin...

EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseases

Thursday, March 30, 2023

EIP Pharma Inc a privately held clinicalstage company focused on developing treatments for neurodegenerative diseases and Diffusion Pharmaceuticals Inc Diffusion or Diffusion Pharmaceuticals today announced that the companies have entered into a defi...

Xeris Biopharma Announces Research Evaluation Collaboration and Option Agreement With Regeneron for XeriJect™

Thursday, March 30, 2023

Xeris Biopharma Holdings Inc a growthoriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic areas today announced that it has entered into a platform...

FDA Approves First Over-the-Counter Naloxone Nasal Spray

Wednesday, March 29, 2023

Today the US Food and Drug Administration approved Narcan milligram mg naloxone hydrochloride nasal spray for overthecounter OTC nonprescription use the first naloxone product approved for use without a prescription Naloxone is a medication that ra...

BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia

Wednesday, March 29, 2023

BGI Genomics is pleased to announce the launch of COLOTECTTM in Slovakia in collaboration with its partner Zentya Zentya is a Slovakbased company that is passionate about providing patients with the latest technology in genetic screening aiming to h...

Lonza Completes Clinical and Commercial Drug Product Manufacturing Line in Visp (CH)

Wednesday, March 29, 2023

Lonza a preferred partner to the pharmaceutical biotech and nutraceutical markets today announced the completion of its planned cGMP clinical and commercial drug product manufacturing line in Visp CH The new line will support customers with a range o...